Incidence and predictors of idiopathic pulmonary fibrosis complicating Type 2 diabetes: the Fremantle Diabetes Study Phase I

Vidya Navaratnam, Timothy M.E. Davis, Richard Hubbard, Wendy A. Davis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

During 106 865 person-years of follow up, 17 (1.3%) Fremantle Diabetes Study Phase I participants with Type 2 diabetes and 57 (1.1%) matched individuals without diabetes developed idiopathic pulmonary fibrosis (IPF), an incidence rate ratio (95% confidence interval) of 1.40 (0.76–2.44) (P = 0.22). In the diabetes cohort, age at diabetes diagnosis and total serum cholesterol (inversely) predicted incident IPF in competing risk multivariable models. The incidence of IPF was low in community-based cohorts, regardless of Type 2 diabetes status.

Original languageEnglish
Pages (from-to)276-279
Number of pages4
JournalInternal Medicine Journal
Volume51
Issue number2
DOIs
Publication statusPublished - Feb 2021

Fingerprint

Dive into the research topics of 'Incidence and predictors of idiopathic pulmonary fibrosis complicating Type 2 diabetes: the Fremantle Diabetes Study Phase I'. Together they form a unique fingerprint.

Cite this